Corbus Pharmaceuticals Gets a Buy Rating from Noble Financial

15May

Corbus Pharmaceuticals Gets a Buy Rating from Noble Financial

Portfolio News

Corbus Pharmaceuticals Holdings, Inc. engages in the development and commercialization of novel therapeutics to treat rare or uncommon chronic and serious inflammatory and fibrotic diseases with clear unmet medical needs. Read more >>

Share this post

Related Posts

28Oct

Anything is possible’: Life-changing tech lets visually impaired Calgary master’s student see clearly

Faizan Kazani, currently in the second year of his master's degree in creativity and change leadership, uses a set of... read more
24Jun

Military Personnel Treated with SAM Therapeutic Ultrasound Are Able to Heal Without Surgery and Oral Medication; Multi-Site Clinical Findings Presented at SOMSA 2021

Dr. George Lewis, founder of ZetrOZ Systems, will present a study at The Special Operations Medical Association's Scientific Assembly 2021... read more
25Jun

The 10 Hottest Tech Startups Of 2020 (So Far)

Wasabi, a provider of hot cloud storage for businesses, in May unveiled a new $30 million round of funding. The... read more
21Mar

Chronix Biomedical Study Demonstrates Its Blood Test Can Predict Response To Cancer Immunotherapy

Chronix Biomedical, Inc., a developer of novel cancer blood-based molecular diagnostics, announces the publication of positive results of a study... read more
14Oct

Skin-care product based on U of T Engineering research donated to health-care workers fighting COVID-19

A U of T Engineering spinoff company has donated its entire stock of skin-care product to health-care workers fighting the... read more
05Apr

Two Babson Ventures Named Startups to Watch by BostInno

BostInno recently named two ventures founded by Babson alumni—High Time Foods and DetraPel—as startups to watch for 2023. In all,... read more
16Mar

How Laurel Taylor Built A Company That Is Helping Crush Student Debt

Boston-based entrepreneur Laurel Taylor has built a company that provides student debt employer benefits solutions. Read more >> read more
06Oct

What is eSight Eyewear and How Can It Help?

Jill Barkley speaks to Jeff Fenton, director of outreach and communications for eSight, about the new technology that enables partially... read more
06Dec

Forbes 30 Under 30

Founder of DetraPel, David Zamarin, is on the list for 2021 Forbes 30 Under 30. Read more >> read more
05Apr

Myomo Reports Progress with China Joint Venture, Receives Partial Payment of Technology License Fee

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,... read more